Covovax gets DCGI’s EUA nod for 12-17-year-olds
The drug regulator has given emergency approval to Serum Institute of India’s Covovax for use in children aged 12-17 years. This is the fourth vaccine to get regulatory approval for use in youngsters.
The drug regulator has given emergency approval to Serum Institute of India’s Covovax for use in children aged 12-17 years. This is the fourth vaccine to get regulatory approval for use in youngsters.